Abstract
Various subgroups of CD8+ T lymphocytes do not only demonstrate cytotoxic effects, but also serve important regulatory roles in the body's immune response. In particular, CD8+ regulatory T cells (CD8+ Tregs), which possess important immunosuppressive functions, are able to effectively block the overreacting immune response and maintain the body's immune homeostasis. In recent years, studies have identified a small set of special CD8+ Tregs that can recognize major histocompatibility complex class Ib molecules, more specifically Qa-1 in mice and HLA-E in humans, and target the self-reactive CD4+ T cells. These findings have generated broad implications in the scientific community and attracted general interest to CD8+ Tregs. The present study reviews the recent research progress on CD8+ Tregs, including their origin, functional classification, molecular markers and underlying mechanisms of action.
Author supplied keywords
Cite
CITATION STYLE
Yu, Y., Ma, X., Gong, R., Zhu, J., Wei, L., & Yao, J. (2018, June 1). Recent advances in CD8+ regulatory t cell research (Review). Oncology Letters. Spandidos Publications. https://doi.org/10.3892/ol.2018.8378
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.